Rhumbline Advisers Biote Corp. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Biote Corp. stock. As of the latest transaction made, Rhumbline Advisers holds 28,225 shares of BTMD stock, worth $172,172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,225
Previous 13,821
104.22%
Holding current value
$172,172
Previous $80,000
162.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BTMD
# of Institutions
75Shares Held
15.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$23 Million12.3% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$14.9 Million6.61% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$9.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$8.42 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.29MShares$7.84 Million0.05% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $46.2M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...